local_hospital

Anima

Address
lock Available on a paid plan

Female Urogenital Health and Sleep-Related Menopause Research

At Anima in Diepenbeek, clinical trials in female urogenital diseases focus on sleep disturbances associated with menopause. This work is aimed at understanding how new therapies may improve nighttime symptoms and overall well-being in women experiencing menopause-related sleep problems.

  • Menopause-related sleep disturbances
  • Female urogenital health
  • Evaluating symptom relief and treatment benefit

The research is centered on improving quality of life by testing whether emerging treatments can ease sleep disruption and related menopausal discomfort.

Virus Disease and Influenza Vaccine Studies

Trials in virus diseases at this site include research on influenza and human papillomavirus. These studies are designed to assess the safety, immune response, and effectiveness of new vaccine approaches and other preventive strategies.

  • Influenza
  • Human papillomavirus
  • Testing vaccine performance and immune protection

This line of research helps determine whether novel vaccines can better protect adults against common viral infections and support stronger public health prevention.

Immune System Disease Research

Immune system diseases are another important focus at Anima, with studies involving systemic lupus erythematosus and rheumatoid arthritis. The trials are exploring new treatment options that may help control inflammation, reduce symptoms, and improve daily functioning.

  • Systemic lupus erythematosus
  • Rheumatoid arthritis
  • Assessing treatment effectiveness and safety

These investigations aim to advance care for chronic autoimmune conditions by identifying therapies that may offer better disease control for patients.

Nutritional and Metabolic Disease Trials

Clinical research in nutritional and metabolic diseases includes studies on obesity and excess body weight. The main purpose is to evaluate whether new medicines can support weight reduction or help maintain weight loss over time.

  • Obesity
  • Weight management and maintenance
  • Testing new treatment approaches for metabolic health

These trials are especially relevant for understanding how emerging therapies may contribute to longer-term weight control and broader metabolic health improvement.

Behavioral and Addiction-Related Research

Within psychiatry and psychology, the site is conducting research on alcohol use disorder. The studies are intended to explore whether new therapies can reduce alcohol consumption and support recovery in people with moderate-to-severe dependence.

  • Alcohol use disorder
  • Behavioral health and addiction care
  • Evaluating reduction in alcohol use

This area of research reflects a growing effort to improve treatment options for substance use disorders through more effective and patient-centered interventions.

Site Overview

assignment
2
connected trials
corporate_fare
3
sponsors
science
1
IMP

Activity Indicator

Last 6 months

1
Trials started
New activity detected vs previous period.
0
Trials started 6–12 months ago
2
Total trials linked
Moderately Active
trending_upGrowing+100%
1
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status
lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
1
Sponsors (total)
3
Active sponsors
1

Sponsor Network

Top 1 by active trials.

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

No repeated partnerships found.

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 307 other sites in Belgium

description
Trial volume
2
Outperforms 60% of sites
public
Therapeutic diversity
2areas
Outperforms 64% of sites
groups
Sponsor diversity
3sponsors
Outperforms 71% of sites

Therapeutic Area Benchmark — Belgium

Select a therapeutic area to compare against other sites in Belgium.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Belgium

Market Share

Country: Belgium

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Anima

lock Showing 1 of 2 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
Efficacy and Safety of Zenagamtide in Participants with Obesity: A Randomized Controlled Trial to Evaluate Weight MaintenanceNovo Nordisk A/SPhase IIIRecruitingApr 2026

IMP list

IMP Trials Status First start Last start
Elinzanetant1Unknown2024-03-142024-03-14

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.